Advances in Myelofibrosis Treatment and Enhancing Patient Quality of Life - Episode 8

Assessing Treatment Response in Patients With Myelofibrosis

January 5, 2024
Christine Cooper, RN, BSN

,
Aaron Gerds, MD, MS

Response is assessed in patients starting a JAK inhibitor by monitoring symptoms on a severity scale, spleen size, blood counts, and overall patient impression of change, with the goal being reduction of symptoms and stabilization of blood counts to improve quality of life.